Back

Results - Announcements

Sales rise 5.69% to Rs 41.05 crore

Jenburkt Pharmaceuticals standalone net profit rises 8.38% in the March 2025 quarter

21-May-2025, 07:37
Net profit of Jenburkt Pharmaceuticals rose 8.38% to Rs 8.54 crore in the quarter ended March 2025 as against Rs 7.88 crore during the previous quarter ended March 2024. Sales rose 5.69% to Rs 41.05 crore in the quarter ended March 2025 as against Rs 38.84 crore during the previous quarter ended March 2024.

For the full year,net profit rose 23.40% to Rs 32.06 crore in the year ended March 2025 as against Rs 25.98 crore during the previous year ended March 2024. Sales rose 6.85% to Rs 151.69 crore in the year ended March 2025 as against Rs 141.97 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	41.05	38.84	6	151.69	141.97	7
OPM %	26.46	25.36	-	26.63	23.33	-
PBDT	12.63	10.98	15	46.66	37.52	24
PBT	11.84	10.36	14	43.93	35.18	25
NP	8.54	7.88	8	32.06	25.98	23